TY - JOUR
T1 - Salvage therapy for patients with lymphoma
AU - Armitage, J. O.
AU - Vose, J. M.
AU - Bierman, P. J.
AU - Bishop, M. R.
PY - 1994
Y1 - 1994
N2 - Although the majority of patients with lymphoma achieve a complete remission with primary therapy, two thirds or more will fail to achieve an initial remission or will eventually relapse from complete remission and require salvage therapy. The response to salvage therapy will depend on a number of factors, including type of lymphoma (Hodgkin's v non-Hodgkin's), stage of disease, type of salvage therapy, prior therapy, number of relapses, and duration of initial remission. In general, the likelihood of attaining a complete remission is greatest with primary therapy and declines with each relapse. Therefore, it is tremendously important that patients with lymphoma be managed optimally at the time of their initial treatment.
AB - Although the majority of patients with lymphoma achieve a complete remission with primary therapy, two thirds or more will fail to achieve an initial remission or will eventually relapse from complete remission and require salvage therapy. The response to salvage therapy will depend on a number of factors, including type of lymphoma (Hodgkin's v non-Hodgkin's), stage of disease, type of salvage therapy, prior therapy, number of relapses, and duration of initial remission. In general, the likelihood of attaining a complete remission is greatest with primary therapy and declines with each relapse. Therefore, it is tremendously important that patients with lymphoma be managed optimally at the time of their initial treatment.
UR - http://www.scopus.com/inward/record.url?scp=0027992305&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027992305&partnerID=8YFLogxK
M3 - Review article
C2 - 8091246
AN - SCOPUS:0027992305
SN - 0093-7754
VL - 21
SP - 82
EP - 85
JO - Seminars in Oncology
JF - Seminars in Oncology
IS - 4 SUPPL. 7
ER -